MedTrace Logo

Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention

NCT01399203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2011-08-03

No results posted yet for this study

Summary

To investigate the predictive value of the contrast media volume to creatinine clearance (V/CrCl) ratio for the risk of contrast-induced nephropathy (CIN) (i.e., within 48-72 h) and to determine a relatively safe V/CrCl cut-off value to avoid CIN in patients following PCI

Conditions

  • Contrast Induced Nephropathy

Sponsors & Collaborators

  • Hainan People's Hospital

    collaborator OTHER

  • Guangdong Medical College

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Yong Liu, MD · Guangdong Provincial People's Hospital

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-10-31
Completion
2012-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01399203 on ClinicalTrials.gov